- Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial. Duinkerke, S.J., Botter, P.A., Jansen, A.A., van Dongen, P.A., van Haaften, A.J., Boom, A.J., van Laarhoven, J.H., Busard, H.L. The British journal of psychiatry : the journal of mental science. (1993)